Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02106936 · ClinicalTrials.gov registry record

Depotentiation in People With Focal Hand Dystonia

A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Terminated
Registry status
6
Enrollment target

NCT02106936 is a clinical trial that was terminated before completion, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 6 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02106936 was terminated before completion, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

TERMINATED
Registry status
6 participants
Enrollment target

Study Summary

Background: \- Focal hand dystonia (FHD) causes muscles to contract, leading to abnormal movements or postures. Musicians, writers, and athletes often get it. Researchers want to study how patients with this condition learn, a process of the brain that depends on a property called plasticity. Objective: \- To study brain plasticity in people with FHD. Eligibility: * Right-handed adults 18 years and older with FHD. * Healthy, right-handed adult volunteers. Design: * Participants will be screened with medical history, physical exam, pregnancy test, and questionnaire about their right-handedness. * Participants will have 2 study visits on 2 different days. * Participants will sit in a chair and have up to 30 Transcranial Magnetic Stimulation (TMS) pulses on the left side of the head. A brief electrical current passes through a wire coil on the scalp. They will hear a click and may feel a pulling on the skin or muscle twitches. They may have to keep their eyes open and remain alert, tense certain muscles, or perform simple finger movements. * Forty more pulses, with 10 seconds between, will be given on the left side of the head. Some will be small, some big. * Researchers will measure muscle response through small electrodes taped to the right hand. * A cloth cap will be put on the participant s head. Researchers will write on tape on the cap. * Participants will have the r-PAS. An electrical stimulator will be placed on the nerve at the right wrist. Repeated magnetic pulses will be delivered in trains or short bursts together with electrical stimulation of nerve. Participants will receive up to 840 pulses. * Participants will be contacted after a few days for a follow-up check.

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2014-03-05
Est. Completion 2017-06-20

What the Registry Record Tells You About NCT02106936

The ClinicalTrials.gov registry entry for NCT02106936 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02106936 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02106936 about?

NCT02106936 is a clinical study titled "Depotentiation in People With Focal Hand Dystonia". Background: \- Focal hand dystonia (FHD) causes muscles to contract, leading to abnormal movements or postures. Musicians, writers, and athletes often get it. Researchers want to study how patients with this condition learn, a process of the brain that depends on a property called plasticity. Obje...

What is the current status of trial NCT02106936?

This trial is currently terminated. The enrollment target is 6 participants. The study started on 2014-03-05. Estimated completion is 2017-06-20.

Who is sponsoring clinical trial NCT02106936?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.